Navigation Links
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
Date:10/11/2007

ebo for six months after an evaluation period of three days to eight weeks and a period of stabilization of four to eight weeks. A total of 71 patients completed the study with a 14.5% dropout rate.

The clinical efficacy endpoint of the study was a reduction in parenteral nutrition (PN) of at least 20% comparing baseline to weeks 16 to 24, measured as a graded response to capture reductions up to 100%.

The dose levels were selected based on the results of the GATTEX Phase 2 proof-of-concept study where doses of 0.03, 0.10 and 0.15 mg/kg/d were administered. Since this study had few subjects in the 0.03 mg/kg/d low dose group, it proved difficult to determine the effects of a low dose. Therefore a low dose of 0.05 mg/kg/d was selected for the Phase 3 study. The highest dose (0.15mg/kg/d) did not seem to provide any additional benefit compared to the 0.10 mg/kg/d dose, therefore the 0.10 mg/kg/d dose was selected as the maximum dose for the Phase 3 study.

Sixteen of the 35 patients (45.7%) receiving the low dose of GATTEX (0.05 milligrams/kilogram/day) demonstrated a 20 percent or greater reduction in parenteral nutrition (PN) (p-value 0.007), compared to eight of 32 patients (25%) in the high-dose group (0.10 mg/kg/day) (p-value 0.161), and one of 16 patients (6%) in the placebo group.

In this Phase 3 study, there were no statistical differences in the incidence rate of adverse events or serious adverse events among the treatment groups when compared to placebo.

Statistical Analysis

The primary endpoint, originally a reduction of 20% or greater in PN measured at weeks 20 to 24, was expanded to account for duration and magnitude of effect. Pair-wise treatment comparisons were made using a rank analysis of covariance with strata for the baseline PN consumption level used for the stratification of the randomization and treatment group with the baseline weekly PN volume as a covariate. A step-down sequential testing procedure was used
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  Diplomat, the nation,s largest independent specialty pharmacy, ... in the 2014 Innovations in Specialty Pharmacy Competition, ... of the competition were announced in the August ... Diplomat was honored as a Top Innovator ... Through Diplomat University, the company has implemented a ...
(Date:8/22/2014)... Ohio , Aug. 22, 2014 MC Medical, ... Inc. (MID), a Columbus, OH medical ... distribute the FloShield laparoscopic and robotic visualization system in ... be approved for sale in Japan ... a long-time experience and an extensive product portfolio in endoscopic ...
(Date:8/22/2014)... , Aug. 22, 2014  Mark Riccio, director ... imaging facility, is using the online crowd-funding platform ... 5D imaging to researchers and would-be superheros everywhere: ... "What would YOU do if you had Superman,s ... researchers and explorers everywhere, from elementary through high ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2
... 16, 2011 Vista Partners announced today that ... CDY) (the "Company") and raised its twelve month target price ... stated, "Cellmid is on track to enter clinical trials for ... the billions. The Company recently completed humanisation of its "first ...
... The federal government,s tracking system for power wheelchairs ... for a new procurement policy implemented last January. Thus, ... of power wheelchairs provided than were actually delivered to ... report declines of 30 percent or more in their ...
Cached Medicine Technology:Vista Partners Updates Coverage on Cellmid Limited; Raises Target Price to AUD $0.12 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 3American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 4
(Date:8/23/2014)... August 23, 2014 A team of New ... last longer when preceded by surgery and delivered by an ... the new study. Click here to read it now ... the cases of mesothelioma patients who underwent hemithoracic ... radiotherapy dose to the shape of a tumor. Patients ...
(Date:8/23/2014)... 2014 The MPWMD Board of Directors voted ... as a sole source of water for commercial and industrial ... architect, Ron Brown of Archworks, LLC in Carmel, California. ... first time a water district in the State of California ... source. AWGs at this time can now be used ...
(Date:8/23/2014)... 23, 2014 Youth substance abuse is ... no different in Houston, TX. Substance abuse can happen ... to drug and alcohol dependency in higher numbers than ... beat substance abuse, but don’t know where to find ... can be a challenge because most treatment options are ...
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a web ... He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) ... , GoDaddy is a popular supplier of cheap web ... solutions at affordable rates. It offers three Linux shared ... depend on the length of the contract. The longest ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 AWeber, ... services that currently helps more than 120,000 small ... caught the attention of Shane Michaels, prompting an investigative ... crucial element for any online marketing campaign, despite what ... in the marketing world,” reports Michaels. “AWeber is a ...
Breaking Medicine News(10 mins):Health News:New Study Links Hospital Experience and Prior Surgery with Mesothelioma Radiation Success, According to Surviving Mesothelioma 2Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2
... cord blood are to be used for regeneration of broken ... €2.5 million to be headed by York University and // ... researchers from department of biology, sociology and Philosophy from York ... blood stem cells in the treatment of bone defects and ...
... as eliminated Leprosy but still we have to eradicate the ... the awareness regarding the // transmission of the bacteria and ... ,Indian Health Minister Dr. Anbumani Ramadoss during the ... eradicate the disease which as about a 1 Lakh of ...
... in New South Wales are angry at a proposal to cut ... spokesman for the medical staff council at Wagga // Base Hospital, ... surgery every fourth Friday. ,"So it'd create a long ... small amount of money but at great cost to patient care," ...
... by researchers from University of Texas has revealed that ... can work wonders in easing depression. // Other ... alcohol, caffeine or smoking are associated with adverse health ... a group of 40 individuals, diagnosed with depression. None ...
... ever study conducted on the prevalence of diabetes in the ... diabetes has been uncovered. // So far, such studies ... which cannot be applied to South Asians. ,The ... and Diabetes Research Centre, an association of the World Health ...
... magnetic resonance imaging (fMRI) can help identify if an ... traditional polygraph tests. // The test further highlights certain ... tells a lie. Researchers from Temple University Hospital in ... in the latest issue of Radiology. ,The ...
Cached Medicine News:Health News:Prevention And Control Of Diabetes Crucial To Indian Population 2Health News:Brain Is More Active While Hiding The Truth, Reveals fMRI Imaging 2
For the quantitative determination of alanine aminotransferase in human serum....
... for the quantitative determination of ... or plasma. Single vial, dry ... must be purchased separately for ... reaction. Wavelength: 340 nm. Linearity: ...
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Medicine Products: